Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calcium Oxalate Labs, Inc. is a healthcare company specializing in the research and development of solutions for calcium oxalate kidney stones. Its flagship product, Kidney C.O.P. (Calcium Oxalate Protector), is a patented dietary supplement formulated with five active ingredients—including magnesium citrate, vitamin B6, and banana stem—that have been shown in laboratory tests to inhibit the growth of calcium oxalate crystals by 99%. The company also offers VELOXA, a line of low-oxalate teas, and educational resources like 'The Ultimate Low Oxalate Diet Cookbook.' Founded by pharmaceutical industry veteran Gregory Hayer, the company aims to provide affordable and effective options for managing kidney health and preventing stone recurrence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calcium Oxalate Labs.